Browsing Centre for Experimental Medicine and Rheumatology (EMR) by Subject "intramuscular methylprednisolone"
Now showing items 1-1 of 1
-
Feasibility randomised multicentre, double-blind, double-dummy controlled trial of anakinra, an interleukin-1 receptor antagonist versus intramuscular methylprednisolone for acute gout attacks in patients with chronic kidney disease (ASGARD): protocol study.
(2017-09-05)INTRODUCTION: Acute gout occurs in people with chronic kidney disease, who are commonly older people with comorbidities such as hypertension, heart disease and diabetes. Potentially harmful treatments are administered to ...